1. Home
  2. WCC vs RGEN Comparison

WCC vs RGEN Comparison

Compare WCC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WESCO International Inc.

WCC

WESCO International Inc.

HOLD

Current Price

$255.75

Market Cap

13.5B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.38

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WCC
RGEN
Founded
1922
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
8.2B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
WCC
RGEN
Price
$255.75
$157.38
Analyst Decision
Strong Buy
Buy
Analyst Count
9
10
Target Price
$255.11
$170.90
AVG Volume (30 Days)
514.3K
724.0K
Earning Date
10-30-2025
10-28-2025
Dividend Yield
0.70%
N/A
EPS Growth
2.23
N/A
EPS
12.73
0.03
Revenue
$22,942,100,000.00
$707,890,000.00
Revenue This Year
$8.59
$17.84
Revenue Next Year
$6.01
$12.57
P/E Ratio
$20.45
$6,185.26
Revenue Growth
5.28
11.74
52 Week Low
$125.21
$102.97
52 Week High
$279.04
$182.52

Technical Indicators

Market Signals
Indicator
WCC
RGEN
Relative Strength Index (RSI) 46.97 47.76
Support Level $252.52 $156.31
Resistance Level $279.04 $165.02
Average True Range (ATR) 8.16 4.62
MACD -2.33 -1.40
Stochastic Oscillator 12.46 9.44

Price Performance

Historical Comparison
WCC
RGEN

About WCC WESCO International Inc.

Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: